Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
SEC14L1 protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SEC14L1 protein | affects expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SEC14L1 mRNA | decreases expression | 20018196
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of SEC14L1 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SEC14L1 mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of SEC14L1 mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of SEC14L1 mRNA | affects cotreatment|increases expression | 17404688
|
D005472 |
Fluorouracil |
SEC14L1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of SEC14L1 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of SEC14L1 mRNA | increases expression | 18037150 18070364
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of SEC14L1 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SEC14L1 mRNA | increases expression | 20106945
|
D019772 |
Topotecan |
SEC14L1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of SEC14L1 mRNA | increases expression | 16508948
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.51 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.51 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.94 | 15504547 16511603 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.94 | 11748828 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
5.13 | 16142846 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.47 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.36 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.36 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.36 | 17289903 17261762 14630087 17018787 12948864 18497071 19861407 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.36 | 15136595 16595493 19217205 16557594 18357371 16110121 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.36 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.80 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.40 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.40 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.70 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.70 | 16799960 17088986 17045692 16332177 18930000 17971768 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.05 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.92 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.92 | 16280240 18986760 16757204 17066447 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.46 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.46 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.46 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.97 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 12621046 15668235 15340226 16354765 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.24 | 17016597 16510598 17287894 17725105 17169374 15001691 16340194 18772588 17172411 17018589 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 15289873 16331619 18949393 18448328 17094418 17695437 17016601 20501625 18509181 17401013 18288408 16524972 17255274 16282729 18383874 15148649 16303861 18802399 14970324 17454858 17594712 16391804 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.91 | 16733453 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.60 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.63 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.63 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.03 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.19 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.19 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.58 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.58 | 16481741 16785472 17638652 15173087 16337965 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.94 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.90 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.44 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.88 | 17440010 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 16354765 16959395 18606429 15340226 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.51 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.11 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.11 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.02 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.08 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.08 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.82 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.82 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
12.82 | 16985049 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.28 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.61 | 18177683 15890375 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.61 | 16603448 18383874 17045692 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.61 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.97 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.97 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.47 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.47 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.91 | 15086387 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.23 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.23 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.69 | 18986760 16757204 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.34 | 16810080 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.64 | 16928823 18239605 18600527 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.78 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.89 | 15176712 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.49 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.95 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.95 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.69 | 16500647 16929163 15113037 19003803 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11118676 11222880 11896295 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.90 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.13 | 16289102 15754350 16644109 12479363 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.13 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.13 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.13 | 19082440 18626508 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.08 | 15538739 18722050 16160472 18286688 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.88 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.71 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.71 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.40 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 16951190 17172411 18396642 17522103 19015929 18567086 17498489 15786421 19084572 16424979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.06 | 16280240 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.95 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |